• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期宫颈癌中循环肿瘤细胞表型的分布

Distribution of circulating tumor cell phenotype in early cervical cancer.

作者信息

Pan Li, Yan Gaoshu, Chen Wenli, Sun Lei, Wang Jichuan, Yang Jialin

机构信息

Radiotherapy Department, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610041, People's Republic of China.

出版信息

Cancer Manag Res. 2019 Jun 17;11:5531-5536. doi: 10.2147/CMAR.S198391. eCollection 2019.

DOI:10.2147/CMAR.S198391
PMID:31354357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6588089/
Abstract

Circulating tumor cells (CTCs) can be classified into three phenotypes based on epithelial-to-mesenchymal transition (EMT) markers, including epithelial CTCs, mesenchymal CTCs, and mixed phenotypic CTCs. This study is aimed to analyze the correlation between CTC phenotypes and the clinicopathological features of patients with early cervical cancer. Peripheral blood samples were obtained from 90 patients with early cervical cancer. CTCs were isolated and classified. The correlations of CTC counts and CTC phenotypes with clinicopathological features of patients were analyzed. The positivity rate for CTCs in patients with stage I-IIA cervical cancer was 90%. An increased CTC number was observed in patients with FIGO stage II, pelvic lymph node metastasis, and lymphovascular involvement. There were 38.89% epithelial CTCs, 23.33% mesenchymal CTCs, and 14.44% mixed phenotypic CTCs, Mesenchymal CTCs were more common in patients with FIGO stage II, pelvic lymph node metastasis, lymphovascular involvement, and deep stromal invasion. CTCs with mesenchymal phenotypes are closely related to pelvic lymph node metastasis and lymphatic vascular invasion in stage I-IIA cervical cancer. Detection of circulating tumor cell phenotypes is helpful for the early diagnosis of cervical cancer micro-metastasis and for the assessment of disease status.

摘要

循环肿瘤细胞(CTCs)可根据上皮-间质转化(EMT)标志物分为三种表型,包括上皮型CTCs、间质型CTCs和混合表型CTCs。本研究旨在分析CTCs表型与早期宫颈癌患者临床病理特征之间的相关性。从90例早期宫颈癌患者中采集外周血样本。分离并分类CTCs。分析CTCs计数和CTCs表型与患者临床病理特征的相关性。I-IIA期宫颈癌患者的CTCs阳性率为90%。在国际妇产科联盟(FIGO)II期、盆腔淋巴结转移和淋巴管浸润患者中观察到CTCs数量增加。上皮型CTCs占38.89%,间质型CTCs占23.33%,混合表型CTCs占14.44%,间质型CTCs在FIGO II期、盆腔淋巴结转移、淋巴管浸润和深层间质浸润患者中更为常见。间质表型的CTCs与I-IIA期宫颈癌的盆腔淋巴结转移和淋巴管浸润密切相关。检测循环肿瘤细胞表型有助于早期诊断宫颈癌微转移和评估疾病状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e196/6588089/ead1fb39bb4e/CMAR-11-5531-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e196/6588089/ece3ce339488/CMAR-11-5531-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e196/6588089/15b8bb8eb7f8/CMAR-11-5531-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e196/6588089/ead1fb39bb4e/CMAR-11-5531-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e196/6588089/ece3ce339488/CMAR-11-5531-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e196/6588089/15b8bb8eb7f8/CMAR-11-5531-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e196/6588089/ead1fb39bb4e/CMAR-11-5531-g0003.jpg

相似文献

1
Distribution of circulating tumor cell phenotype in early cervical cancer.早期宫颈癌中循环肿瘤细胞表型的分布
Cancer Manag Res. 2019 Jun 17;11:5531-5536. doi: 10.2147/CMAR.S198391. eCollection 2019.
2
Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.结直肠癌循环肿瘤细胞中上皮和间充质标志物的表达及其临床意义
Oncotarget. 2017 Feb 7;8(6):9293-9302. doi: 10.18632/oncotarget.14065.
3
Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.循环肿瘤细胞中上皮-间充质转化标志物的分子检测:在临床实践中的潜在作用。
World J Gastroenterol. 2019 Jan 7;25(1):138-150. doi: 10.3748/wjg.v25.i1.138.
4
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.基于上皮-间充质转化标志物的循环肿瘤细胞表型检测在 HER2 阴性转移性乳腺癌一线化疗中的预后和治疗意义。
Cancer Commun (Lond). 2019 Jan 3;39(1):1. doi: 10.1186/s40880-018-0346-4.
5
Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.上皮-间质转化导致前列腺癌临床前模型中循环肿瘤细胞检测和转移的疾病阶段差异。
Oncotarget. 2016 Nov 15;7(46):76125-76139. doi: 10.18632/oncotarget.12682.
6
Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.循环肿瘤细胞表型预示着肝癌手术后生存和复发不良。
Dig Dis Sci. 2018 Sep;63(9):2373-2380. doi: 10.1007/s10620-018-5124-2. Epub 2018 Jun 21.
7
Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer.循环肿瘤细胞上皮-间充质转化表型与结直肠癌患者临床病理特征的相关性。
Dis Markers. 2017;2017:9474532. doi: 10.1155/2017/9474532. Epub 2017 Dec 21.
8
Classification of circulating tumor cells by epithelial-mesenchymal transition markers.通过上皮-间质转化标志物对循环肿瘤细胞进行分类。
PLoS One. 2015 Apr 24;10(4):e0123976. doi: 10.1371/journal.pone.0123976. eCollection 2015.
9
Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.基于上皮-间质转化分析循环肿瘤细胞亚群的激素受体状态:关于循环肿瘤细胞异质性的原理验证研究
Oncotarget. 2016 Oct 4;7(40):65993-66002. doi: 10.18632/oncotarget.11787.
10
Significance of circulating tumor cells detection in tumor diagnosis and monitoring.循环肿瘤细胞检测在肿瘤诊断和监测中的意义。
BMC Cancer. 2023 Dec 6;23(1):1195. doi: 10.1186/s12885-023-11696-3.

引用本文的文献

1
PD-L1 CD49f CD133 Circulating tumor cells predict outcome of patients with vulvar or cervical cancer after radio- and chemoradiotherapy.程序性死亡配体1(PD-L1)、整合素α6(CD49f)、CD133循环肿瘤细胞可预测外阴癌或宫颈癌患者放化疗后的预后。
J Transl Med. 2025 Mar 13;23(1):321. doi: 10.1186/s12967-025-06277-w.
2
Detecting epithelial-mesenchymal transition signaling molecules in cervical epithelial cells aids in the early diagnosis of cervical lesions.检测宫颈上皮细胞中的上皮-间质转化信号分子有助于宫颈病变的早期诊断。
BMC Cancer. 2024 Dec 27;24(1):1582. doi: 10.1186/s12885-024-13355-7.
3
New insights into the correlations between circulating tumor cells and target organ metastasis.

本文引用的文献

1
Detection of Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells in Patients with Esophageal Squamous Carcinoma.检测食管鳞癌患者循环肿瘤细胞的上皮-间充质转化状态。
Biomed Res Int. 2018 Jun 26;2018:7610154. doi: 10.1155/2018/7610154. eCollection 2018.
2
Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses.循环肝癌细胞中的 Twist 表达预测转移和预后。
Biomed Res Int. 2018 Jun 26;2018:3789613. doi: 10.1155/2018/3789613. eCollection 2018.
3
The expression of circulating tumor cells in peripheral blood of patients with non-small cell lung cancer and its detection.
循环肿瘤细胞与靶器官转移相关性的新见解。
Signal Transduct Target Ther. 2023 Dec 21;8(1):465. doi: 10.1038/s41392-023-01725-9.
4
Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer.多分析物液体活检辅助乳腺癌的诊断检查
NPJ Breast Cancer. 2022 Sep 27;8(1):112. doi: 10.1038/s41523-022-00480-4.
5
Emerging Technologies for the Detection of Cancer Micrometastasis.癌症微转移检测的新兴技术。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221100355. doi: 10.1177/15330338221100355.
6
A meta-analysis of the prognostic value of circulating tumor cells in ovarian cancer.循环肿瘤细胞在卵巢癌中预后价值的荟萃分析。
Am J Transl Res. 2022 Jun 15;14(6):3574-3583. eCollection 2022.
7
Research on the Guiding Effect of CTCs on Postoperative Adjuvant Therapy for Patients with Early Stage Endometrial Cancer.循环肿瘤细胞对早期子宫内膜癌患者术后辅助治疗的指导作用研究
J Oncol. 2022 May 31;2022:4327977. doi: 10.1155/2022/4327977. eCollection 2022.
8
Application of Microfluidics in Detection of Circulating Tumor Cells.微流控技术在循环肿瘤细胞检测中的应用。
Front Bioeng Biotechnol. 2022 May 12;10:907232. doi: 10.3389/fbioe.2022.907232. eCollection 2022.
9
Liquid Biopsy in Cervical Cancer: Hopes and Pitfalls.宫颈癌中的液体活检:希望与陷阱
Cancers (Basel). 2021 Aug 5;13(16):3968. doi: 10.3390/cancers13163968.
10
A Review of Circulating Tumour Cell Enrichment Technologies.循环肿瘤细胞富集技术综述
Cancers (Basel). 2021 Feb 26;13(5):970. doi: 10.3390/cancers13050970.
非小细胞肺癌患者外周血循环肿瘤细胞的表达及其检测。
J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4):843-849.
4
The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.液体活检在非小细胞肺癌中的现状与未来:联合四种生物源进行诊断、预后、预测和疾病监测。
Curr Oncol Rep. 2018 Jul 20;20(9):70. doi: 10.1007/s11912-018-0720-z.
5
Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.循环肿瘤细胞及其促进癌症转移和复发的进展,重点关注多形性胶质母细胞瘤。
Exp Mol Pathol. 2018 Oct;105(2):166-174. doi: 10.1016/j.yexmp.2018.07.007. Epub 2018 Jul 18.
6
Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.循环肿瘤细胞中间充质标志物和 LGR5 表达水平与结直肠癌预后相关。
Cell Oncol (Dordr). 2018 Oct;41(5):495-504. doi: 10.1007/s13402-018-0386-4. Epub 2018 Jun 14.
7
Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.循环肿瘤细胞表型预示着肝癌手术后生存和复发不良。
Dig Dis Sci. 2018 Sep;63(9):2373-2380. doi: 10.1007/s10620-018-5124-2. Epub 2018 Jun 21.
8
Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.循环肿瘤细胞发生 EMT 为肝细胞癌患者的诊断和预后提供了一个指标。
Cancer Res. 2018 Aug 15;78(16):4731-4744. doi: 10.1158/0008-5472.CAN-17-2459. Epub 2018 Jun 18.
9
Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer.门静脉中循环肿瘤细胞的检测与晚期胰腺癌患者的肝内转移及预后相关。
J Cancer. 2018 May 22;9(11):2038-2045. doi: 10.7150/jca.23989. eCollection 2018.
10
Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells.胃癌的预后和预测性血液生物标志物及循环肿瘤细胞的潜在应用。
World J Gastroenterol. 2018 Jun 7;24(21):2236-2246. doi: 10.3748/wjg.v24.i21.2236.